Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Print  

Study Name: Inhaled Glutathione in People with CF
Study Type: Interventional
Intervention Category: Anti-Inflammatory
Study Sponsor: Griese, Matthias

Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Study Phase: 2
Recruitment Status: Trial Completed
Study Drug(s): Glutathione (Inhaled)
Number of Participants Being Recruited: 138
Single / Multi-Center: Multi-Center
STUDY BACKGROUND INFORMATION:
This study will evaluate the safety and tolerability of aerolized glutathione compared with normal saline. The main outcome measure is pulmonary function testing (PFT).
ELIGIBILITY
Age: >= 8 Years
FEV1: 40 - 90 Percent Predicted
P. aeruginosa status: Not applicable
B. cepacia status: Negative
Other Primary Eligibility Requirements:

Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
FOR MORE INFORMATION:
Sponsor Contact Information: Griese, Matthias
(11) 4989-5160 X7870
Matthias.Griese@med.uni-muenchen.de
Trial Specific Link on ClinicalTrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT00506688?term=glutathione+and+cystic+fibrosis&rank=1
Clinical Research Terms Glossary: Click here
Back to top